000			01648 a2200445 4500
005			20250513130153.0
264		0	_c19971104
008			199711s 0 0 eng d
022			_a0003-990X
024	7		_a10.1001/archpsyc.1997.01830220079011 _2doi
040			_aNLM _beng _cNLM
100	1		_aNyberg, S
245	0	0	_aDelayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings. _h[electronic resource]
260			_bArchives of general psychiatry _cOct 1997
300			_a953-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAntipsychotic Agents _xpharmacokinetics
650	0	4	_aBasal Ganglia _xdiagnostic imaging
650	0	4	_aBrain _xdiagnostic imaging
650	0	4	_aDelayed-Action Preparations _xpharmacokinetics
650	0	4	_aDopamine Antagonists
650	0	4	_aFemale
650	0	4	_aHaloperidol _xanalogs & derivatives
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMathematics
650	0	4	_aMiddle Aged
650	0	4	_aPutamen _xdiagnostic imaging
650	0	4	_aRaclopride
650	0	4	_aRadioligand Assay
650	0	4	_aReceptors, Dopamine D2 _xanalysis
650	0	4	_aSalicylamides
650	0	4	_aSchizophrenia _xdiagnostic imaging
650	0	4	_aTomography, Emission-Computed
700	1		_aFarde, L
700	1		_aHalldin, C
773	0		_tArchives of general psychiatry _gvol. 54 _gno. 10 _gp. 953-8
856	4	0	_uhttps://doi.org/10.1001/archpsyc.1997.01830220079011 _zAvailable from publisher's website
999			_c9309779 _d9309779